Does Rallies track congressional trades in MASI?

Yes. Rallies tracks politician and congressional stock disclosures for MASI, including reported purchases, sales, dates, owners, and trade amounts when available.

Is MASI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MASI. It does not provide personalized investment advice.

MASI (Masimo Corporation) Stock Analysis - Politician Trades

Masimo Corporation (MASI) is a publicly traded Healthcare sector company. As of May 20, 2026, MASI trades at $178.81 with a market cap of $9.36B and a P/E ratio of -63.18. MASI moved +0.01% today. Year to date, MASI is +33.43%; over the trailing twelve months it is +14.48%. Its 52-week range spans $125.94 to $194.88. Analyst consensus is neutral with an average price target of $180.00. Rallies surfaces MASI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded MASI stock?

Recent politician trading activity in MASI includes disclosures from Kevin Hern, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

MASI Key Metrics

Key financial metrics for MASI
Metric	Value
Price	$178.81
Market Cap	$9.36B
P/E Ratio	-63.18
EPS	$-2.83
Dividend Yield	1.00%
52-Week High	$194.88
52-Week Low	$125.94
Volume	703.10K
Avg Volume	0
Revenue (TTM)	$1.53B
Net Income	$-151.50M
Gross Margin	61.90%

Congressional Trades in MASI

Kevin Hern sale MASI on Sep 26, 2025 (amount: $50.00K) for Joint.
Tommy Tuberville sale (full) MASI on Oct 5, 2022 (amount: $15.00K) for Joint.
Tommy Tuberville purchase MASI on Mar 30, 2022 (amount: $15.00K) for Joint.

Latest MASI News

Masimo Reports <1% Bias in Newborn Pulse Oximetry, Zero Occult Events in Black, Hispanic Infants — Apr 28, 2026
Masimo’s $180 Share Sale to Danaher Faces Shareholder Fairness Probe — Apr 10, 2026
Masimo Shares Up 28.2% Past Six Months, Trades at 5.74 P/S Ratio — Mar 2, 2026
Law Firm Probes Masimo’s $180-per-Share Cash Acquisition by Danaher — Feb 25, 2026
Masimo Sees FY24 Healthcare Revenues Up 9.4%, Growth Score A Forecasts 23.9% — Feb 20, 2026

Recent MASI Insider Trades

Sampath Anand sold 11.92K (~$1.63M) on Jan 28, 2026.
Sampath Anand sold 6.56K (~$900.16K) on Jan 28, 2026.
Sampath Anand sold 196 (~$27.07K) on Jan 28, 2026.

MASI Analyst Consensus

3 analysts cover MASI: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $180.00.

Common questions about MASI

Which politicians traded MASI stock?: Recent politician trading activity in MASI includes disclosures from Kevin Hern, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in MASI?: Yes. Rallies tracks politician and congressional stock disclosures for MASI, including reported purchases, sales, dates, owners, and trade amounts when available.
Is MASI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MASI. It does not provide personalized investment advice.